Christoph Niederhauser

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


86 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
 
Prevalence of anti-tick-borne encephalitis virus (TBEV) antibodies in Swiss blood donors in 2014-2015.
Ackermann-Gäumann R., Eyer C., Vock M., Gowland P., Tinguely C., Leib S.L., Bori M., Buser A., Fontana S., Thierbach J. et al., 2023/03. Blood transfusion = Trasfusione del sangue, 21 (2) pp. 100-109. Peer-reviewed.
Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum.
Niederhauser C., Tinguely C., Stolz M., Vock M., El Dusouqui S.A., Gowland P., 2022/11/23. Viruses, 14 (12) p. 2611. Peer-reviewed.
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Purde M.T., Niederer R., Wagner N.B., Diem S., Berner F., Hasan Ali O., Hillmann D., Bergamin I., Joerger M., Risch M. et al., 2022/03. Journal of cancer research and clinical oncology, 148 (3) pp. 647-656. Peer-reviewed.
 
Comparison of a New IgG-EIA for the Detection of Anti-Plasmodium Antibodies with Two Currently Used Assays.
Niederhauser C., Tinguely C., Dreier J., Vollmer T., Marti H.P., Nickel B., Klemens J.M., Warnecke J.M., Gowland P., 2021/10. Transfusion medicine and hemotherapy, 48 (5) pp. 265-271. Peer-reviewed.
 
Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
Voruz S., Gowland P., Eyer C., Widmer N., Abonnenc M., Prudent M., Masouridi-Levrat S., Duchosal M.A., Niederhauser C., 2020/11. Blood transfusion = Trasfusione del sangue, 18 (6) pp. 446-453. Peer-reviewed.
The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial.
Keller P., von Känel R., Hincapié C.A., da Costa B.R., Jüni P., Erlanger T.E., Andina N., Niederhauser C., Lämmle B., Fontana S., 2020/08/26. Scientific reports, 10 (1) p. 14219. Peer-reviewed.
 
Reduced RhD antigen expression caused by two novel RHD variant alleles.
Stettler J., Lejon Crottet S., Still F., Graber J., Niederhauser C., Waldvogel S., Henny C., 2020/04. Transfusion, 60 (4) pp. E7-E8. Peer-reviewed.
 
Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country.
Stolz M., Gowland P., Tinguely C., Niederhauser C., 2019/04. Transfusion medicine and hemotherapy, 46 (2) pp. 104-110. Peer-reviewed.
 
Comparison of Four Commercial IgG-Enzyme-Linked Immunosorbent Assays for the Detection of Tick-Borne Encephalitis Virus Antibodies
Ackermann-Gäumann Rahel, Eyer Claudia, Leib Stephen L., Niederhauser Christoph, 2018/12/04. Vector-Borne and Zoonotic Diseases, 19 (5) pp. 358-364.
Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016
Niederhauser Christoph, Widmer Nadja, Hotz Magdalena, Tinguely Caroline, Fontana Stefano, Allemann Gabrielle, Borri Mauro, Infanti Laura, Sarraj Amira, Sigle Jörg et al., 2018/08/30. Eurosurveillance, 23 (35).
 
Hepatitis E blood donor screening - More than a mere drop in the ocean?
Müllhaupt B., Niederhauser C., 2018/07. Journal of hepatology, 69 (1) pp. 8-10. Peer-reviewed.
 
Transfusionsbedingte Infektionen: Wie sinnvoll und kostspielig ist die Testung auf neue Infektionserreger? [Transfusion-transmitted Infections: How Useful and Costly is Testing for new Infectious Disease Pathogens?]
Niederhauser C., 2018/04. Praxis, 107 (9-10) pp. 521-529. Peer-reviewed.
Editorial: Transfusion Medicine and Blood.
Prudent M., Tissot J.D., Fontana S., Niederhauser C., 2018. Frontiers in medicine, 5 p. 355. Peer-reviewed.
 
West Nile Virus preparedness plan to ensure safe blood components in Switzerland: a risk-based approach
Niederhauser C., Fontana S., Glauser A., Steinemann C., Koller A., 2017/05. ISBT Science Series, 12 (2) pp. 314-321.
Hepatitis E and blood donation safety in selected European countries: a shift to screening?
Domanović D., Tedder R., Blümel J., Zaaijer H., Gallian P., Niederhauser C., Sauleda Oliveras S., O'Riordan J., Boland F., Harritshøj L. et al., 2017/04/20. Euro surveillance, 22 (16). Peer-reviewed.
 
Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing : HBV DETECTION IN A MULTI-REGIONAL STUDY
Lelie Nico, Bruhn Roberta, Busch Michael, Vermeulen Marion, Tsoi Wai-Chiu, Kleinman Steven, Niederhauser Christoph, 2017/01. Transfusion, 57 (1) pp. 24-35.
 
Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate.
Gowland P., Fontana S., Stolz M., Andina N., Niederhauser C., 2016/05. Transfusion medicine and hemotherapy, 43 (3) pp. 198-202. Peer-reviewed.
 
Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.
Niederhauser C., Gottschalk J., Tinguely C., 2016/05. Transfusion medicine and hemotherapy, 43 (3) pp. 169-176. Peer-reviewed.
Impact of naturally occurring amino acid variations on the detection of HIV-1 p24 in diagnostic antigen tests.
Vetter B.N., Orlowski V., Niederhauser C., Walter L., Schüpbach J., 2015/10/29. BMC infectious diseases, 15 p. 468. Peer-reviewed.
 
Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R., Lelie N., Busch M., Kleinman S., International NAT Study Group, 2015/06. Transfusion, 55 (6) pp. 1195-1205. Peer-reviewed.
Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms.
Schüpbach J., Niederhauser C., Yerly S., Regenass S., Gorgievski M., Aubert V., Ciardo D., Klimkait T., Dollenmaier G., Andreutti C. et al., 2015. Plos One, 10 (7) pp. e0131828. Peer-reviewed.
 
Comparison of a conventional HIV 1/2 line immunoassay with a rapid confirmatory HIV 1/2 assay.
Tinguely C., Schild-Spycher T., Bahador Z., Gowland P., Stolz M., Niederhauser C., 2014. Journal of Virological Methods, 206 pp. 1-4. Peer-reviewed.
Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests.
Vetter B.N., Orlowski V., Fransen K., Niederhauser C., Aubert V., Brandenberger M., Ciardo D., Dollenmaier G., Klimkait T., Regenass S. et al., 2014. Plos One, 9 (10) pp. e111552.
 
Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
Stolz M., Tinguely C., Fontana S., Niederhauser C., 2014. Transfusion, 54 (11) pp. 2961-2967. Peer-reviewed.
 
Implementation of a mandatory donor RHD screening in Switzerland.
Crottet S.L., Henny C., Meyer S., Still F., Stolz M., Gottschalk J., Neuenschwander K., Taleghani B.M., Gowland P., Frey B.M. et al., 2014. Transfusion and Apheresis Science, 50 (2) pp. 169-174. Peer-reviewed.
 
Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors.
Gowland P., Gassner C., Hustinx H., Stolz M., Gottschalk J., Tissot J.D., Thierbach J., Maier A., Sigurdardottir S., Still F. et al., 2014. Transfusion and Apheresis Science, 50 (2) pp. 163-168. Peer-reviewed.
 
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care.
Lieberman L., Devine D.V., Reesink H.W., Panzer S., Wong J., Raison T., Benson S., Pink J., Leitner G.C., Horvath M. et al., 2014. Vox Sanguinis, 107 (3) pp. 276-311. Peer-reviewed.
 
Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
Sigle J.P., Thierbach J., Infanti L., Muriset M., Hunziker G., Chassot K., Niederhauser C., Gowland P., Holbro A., Sunic K. et al., 2013. Vox Sanguinis, 105 (3) pp. 244-252. Peer-reviewed.
 
Das schweizerische HIV Testkonzept - eine akutalisierte Version. Concept suisse de test VIH: récapitulatif actualisé.
Schüpbach J., Niederhauser C., Andreutti C., Gorgievski M., Klimkait T., Martinetti G., Regenass S., Yerly S., Aubert V., Brandenberger M. et al., 2013. BAG Bulletin, 47 pp. 851-853.
 
Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
Bruhn R., Lelie N., Custer B., Busch M., Kleinman S., International NAT Study Group, 2013. Transfusion, 53 (10 Pt 2) pp. 2399-2412.
 
Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.
Lejon Crottet S., Haer-Wigman L., Gowland P., Fontana S., Niederhauser C., Hustinx H., 2013. Transfusion, 53 (11 Suppl 2) pp. 3000-3008. Peer-reviewed.
 
Seroprevalence of hantavirus infections in Switzerland in 2009: difficulties in determining prevalence in a country with low endemicity.
Engler O., Klingstrom J., Aliyev E., Niederhauser C., Fontana S., Strasser M., Portmann J., Signer J., Bankoul S., Frey F. et al., 2013. Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 18 (50) p. 20660.
Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.
Schüpbach J., Gebhardt M.D., Scherrer A.U., Bisset L.R., Niederhauser C., Regenass S., Yerly S., Aubert V., Suter F., Pfister S. et al., 2013. Plos One, 8 (8) pp. e71662.
Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.
Schüpbach J., Bisset L.R., Gebhardt M.D., Regenass S., Bürgisser P., Gorgievski M., Klimkait T., Andreutti C., Martinetti G., Niederhauser C. et al., 2012. Bmc Infectious Diseases, 12 p. 88.
 
Hepatitis B virus in transfusion medicine: still a problem?
Allain J.P., Candotti D., ISBT HBV Safety Collaborative Group, 2012. Biologicals : Journal of the International Association of Biological Standardization, 40 (3) pp. 180-186.
 
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.
Roth W.K., Busch M.P., Schuller A., Ismay S., Cheng A., Seed C.R., Jungbauer C., Minsk P.M., Sondag-Thull D., Wendel S. et al., 2012. Vox Sanguinis, 102 (1) pp. 82-90. Peer-reviewed.
 
Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother.
Niederhauser C., Candotti D., Weingand T., Maier A., Tinguely C., Stolz M., Allain J.P., 2012. Journal of Hepatology, 56 (3) pp. 734-737.
 
Genotypisierung von Spendern und Patienten.
Niederhauser C., Crottet Lejon S., 2011. Pipette 5 pp. 16-18.
 
Hepatitis B-Virus: Sicherheit von labilen Blutprodukten.
Niederhauser C., Stolz M., 2011. Pipette 6 pp. 20-22.
 
Reducing the risk of hepatitis B virus transfusion-transmitted infection.
Niederhauser C., 2011. Journal of Blood Medicine, 2 pp. 91-102.
 
11 Jahre nationales Zentrum für Infektionen durch Blut und Blutprodukte.
Niederhauser C., 2010. BAG Bulletin, 10 pp. 336-344.
 
Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region.
Stolz M., Tinguely C., Graziani M., Fontana S., Gowland P., Buser A., Michel M., Canellini G., Züger M., Schumacher P. et al., 2010. Transfusion, 50 (12) pp. 2695-2706. Peer-reviewed.
 
Fatal outcome of a hepatitis B virus transfusion-transmitted infection.
Niederhauser C., Weingand T., Candotti D., Maier A., Tinguely C., Wuillemin W.A., Gowland P., Allain J.P., Stolz M., 2010. Vox Sanguinis, 98 (4) pp. 504-507.
 
Editorial zum Themenheft «Transfusionsmedizin»
Niederhauser C., 2009. Pipette 4 p. 8.
 
Molecular basis of the Rh antigen RH48 (JAL).
Hustinx H., Poole J., Bugert P., Gowland P., Still F., Fontana S., Scharberg E.A., Tilley L., Daniels G., Niederhauser C., 2009. Vox Sanguinis, 96 (3) pp. 234-239. Peer-reviewed.
 
The risk of a second diagnostic window with 4th generation HIV assays: Two cases.
Niederhauser C., Ströhle A., Stolz M., Müller F., Tinguely C., 2009. Journal of Clinical Virology, 45 (4) pp. 367-369.
 
Von der Erbsubstanz über die molekulare Blutgruppendiagnostik zum Routinescreening des Rhesus-D-Gens bei Blutspendern
Niederhauser C., Hustinx H., 2009. Pipette 4 pp. 13-16.
 
Will Genotyping Replace Serology in Future Routine Blood Grouping? - Opinion 2.
Hustinx H., Fontana S., Gowland P., Niederhauser C., 2009. Transfusion Medicine and Hemotherapy, 36 (3) pp. 228-229. Peer-reviewed.
Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
Niederhauser C., Mansouri Taleghani B., Graziani M., Stolz M., Tinguely C., Schneider P., 2008/03/08. Swiss medical weekly, 138 (9-10) pp. 134-141. Peer-reviewed.
 
Donors with a rare pheno (geno) type.
Reesink H.W., Engelfriet C.P., Schennach H., Gassner C., Wendel S., Fontão-Wendel R., de Brito M.A., Sistonen P., Matilainen J., Peyrard T. et al., 2008. Vox Sanguinis, 95 (3) pp. 236-253. Peer-reviewed.
 
Occult hepatitis B infection in blood donors.
Reesink H.W., Engelfriet C.P., Henn G., Mayr W.R., Delage G., Bernier F., Krusius T., Assal A., Gallian P., Corbi C. et al., 2008. Vox Sanguinis, 94 (2) pp. 153-166.
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
Schüpbach J., Gebhardt M.D., Tomasik Z., Niederhauser C., Yerly S., Bürgisser P., Matter L., Gorgievski M., Dubs R., Schultze D. et al., 2007. PLoS Medicine, 4 (12) pp. e343.
 
Das schweizerische HIV-Testkonzept - aktualisierte Übersicht über Technisches Konzept und Laborkonzept.
Andreuti C., Bürgisser P., Dubs R., Steffen I., Gebhardt M., Gorgievski M., Güntert B., Martinetti G., Matter L., Niederhauser C. et al., 2006. BAG Bulletin, 51 (6) pp. 1022-1034.
 
Jahresbericht 2005: Neugeborenen-Screening in der Schweiz.
Niederhauser C, Torresani T., Steinmann B., 2006. Paediatrica, 17 (4) pp. 45-46.
 
Transfusion Medicine in Switzerland.
Lévy G., Byland C., Niederhauser C., Schwabe R., Senn M., Mansouri Taleghani B., 2006. Transfusion Medicine and Hemotherapy, 33 (5) pp. 393-400. Peer-reviewed.
 
Centres de contrôle de qualité en Suisse.
Risch L., Byland C., Niederhauser C., Deom A., Fried R., 2005. Pipette 1 pp. 8-9.
 
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.
Coste J., Reesink H.W., Engelfriet C.P., Laperche S., Brown S., Busch M.P., Cuijpers H.T., Elgin R., Ekermo B., Epstein J.S. et al., 2005. Vox Sanguinis, 88 (4) pp. 289-303. Peer-reviewed.
 
Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.
Niederhauser C., Schneider P., Fopp M., Ruefer A., Lévy G., 2005. Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 10 (2) pp. 14-16.
 
Jahresbericht 2004: Neugeborenen-Screening in der Schweiz.
Niederhauser C., Steinmann B., 2005. Paediatrica, 16 (2) pp. 36-37.
 
Sicherheit von Blutprodukten bezüglich viraler Infektionen.
Niederhauser C., 2005. Pipette 3 pp. 6-12.
 
Die medizinischen Qualitätskontrollzentren der Schweiz.
Risch L, Byland C, Niederhauser C, Deom A, Fried R, 2004. Pipette, 3 pp. 24-25.
 
Fachkommission Labor und Diagnostik: Diagnostische Empfehlung. HIV-Testkonzept 2004: Neue Richtlinien zum Screening.
Bürgisser Ph., Dubs W., Erb P., Fierz W., Gebhardt M., Gorgievski M., Güntert B., Matter L., Niederhauser C., Perrin L. et al., 2004. BAG Bulletin, 10 (4) pp. 168-170.
 
Jahresbericht 2003: Neugeborenen-Screening in der Schweiz.
Niederhauser C., Steinmann B., 2004. Paediatrica, 15 (2) pp. 35-36.
 
Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus.
Gowland P., Fontana S., Niederhauser C., Taleghani B.M., 2004. Transfusion, 44 (11) pp. 1555-1561. Peer-reviewed.
 
Hepatitis C virus-polymerase chain reaction minipool testing: 3 years in the largest Swiss blood transfusion service.
Stolz M., Gilgen M., Niederhauser C., 2003. Vox Sanguinis, 84 (2) pp. 105-110. Peer-reviewed.
 
Improved sensitivity of the Chlamydia trachomatis Cobas Amplicor assay using an optimized procedure for preparation of specimens.
Niederhauser C., Kaempf L., 2003. European Journal of Clinical Microbiology and Infectious Diseases, 22 (2) pp. 118-121. Peer-reviewed.
 
Jahresbericht 2002: Neugeborenen-Screening in der Schweiz.
Niederhauser C., Steinmann B., 2003. Paediatrica, 14 (2) pp. 46-48.
The right choice for the job.
Graziani M, Niederhauser C., 2003. Tecan Journal, 1 pp. 10-11.
 
Jahresbericht 2001: Neugeborenen-Screening in der Schweiz.
Niederhauser C., Steinmann B., 2002. Paediatrica, 13 (2) pp. 57-59.
 
Transfusion-associated Hepatitis A Virus (HAV) Window Period Infection: Documented Re-Infection of a Patient.
Gowland P, Fontana S, Niederhauser C, Mansouri Taleghani B., 2002. Infusion Therapy and Transfusion Medicine, 29 (S1) pp. 22-23.
 
Detection limit, cut-off and specificity of an improved rapid assay for cardiac troponin T.
Baum H., Bertsch T., Bohner J., von Pap K.W., Hoff T., Wilke B., Katz N., Luthe H., Luz H., Nagel D. et al., 2001. Clinical Laboratory, 47 (11-12) pp. 549-554. Peer-reviewed.
 
Jahresbericht 2000: Neugeborenen-Screening in der Schweiz
Niederhauser C., Steinmann B., 2001. Paediatrica, 12 (4) pp. 63-65.
 
Neonatale Bluttransfusion und Hepatitis C im Erwachsenenalter.
Niederhauser C., 2001. Paediatrica, 12 (4) pp. 54-56.
 
Chlamydienscreening: Ist das Nachweisproblem gelöst [Screening of Chlamydia trachomatis: is the diagnostic efficacy good enough?].
Niederhauser C., Honegger C., Kaempf L., 2000. Gynäkologisch-geburtshilfliche Rundschau, 40 (3-4) pp. 134-139.
 
Ist die Diagnose einer konnatalen Zytomegalie Infektion im Nachhinein in der Schweiz möglich ?
Niederhauser C., 2000. Paediatrica, 11 pp. 43-44.
 
Use of the ligase detection reaction-polymerase chain reaction to identify point mutations in extended-spectrum beta-lactamases.
Niederhauser C., Kaempf L., Heinzer I., 2000. European Journal of Clinical Microbiology and Infectious Diseases, 19 (6) pp. 477-480. Peer-reviewed.
 
Gentechnologisch veränderte pflanzliche Lebensmittel : Stand der anwendungsorientierten Forschung und potentielle Nachweismöglichkeiten mit molekularbiologischen Methoden [Genetically engineered food plants : Research and detection with DNA-analytical methods]
Niederhauser C., Gilgen M., Meyer R., 1996. Mitteilungen aus dem Gebiete der Lebensmitteluntersuchung und Hygiene, 87 (3) pp. 307-367.
 
Polymerase chain reaction (PCR) for detection of pathogenic microorganisms in bacteriological monitoring of dairy products.
Allmann M., Höfelein C., Köppel E., Lüthy J., Meyer R., Niederhauser C., Wegmüller B., Candrian U., 1995. Research in Microbiology, 146 (1) pp. 85-97. Peer-reviewed.
 
Direct detection of Listeria monocytogenes using paramagnetic bead DNA extraction and enzymatic DNA amplification.
Niederhauser C., Lüthy J., Candrian U., 1994. Molecular and Cellular Probes, 8 (3) pp. 223-228. Peer-reviewed.
 
Random amplification of polymorphic bacterial DNA: evaluation of 11 oligonucleotides and application to food contaminated with Listeria monocytogenes.
Niederhauser C., Höfelein C., Allmann M., Burkhalter P., Lüthy J., Candrian U., 1994. Journal of Applied Bacteriology, 77 (5) pp. 574-582. Peer-reviewed.
 
Reliability of PCR decontamination systems.
Niederhauser C., Höfelein C., Wegmüller B., Lüthy J., Candrian U., 1994. Pcr Methods and Applications, 4 (2) pp. 117-123.
 
Comparison of "Gen-Probe" DNA probe and PCR for detection of Listeria monocytogenes in naturally contaminated soft cheese and semi-soft cheese.
Niederhauser C., Höfelein C., Lüthy J., Kaufmann U., Bühler H.P., Candrian U., 1993. Research In Microbiology, 144 (1) pp. 47-54. Peer-reviewed.
 
Nachweis und Charakterisierung von Listeria monocytogenes in Lebensmitteln und klinischem Material.
Niederhauser C., Candrian U., Höfelein C., Lüthy J., 1993. Lebensmittelchemie, 47 p. 67. Peer-reviewed.
 
Ultra sensitive detection of Listeria monocytogenes in milk by PCR.
Candrian U, Niederhauser C., 1993. Letters in Applied Microbiology, 17 p. 144. Peer-reviewed.
 
Use of polymerase chain reaction for detection of Listeria monocytogenes in food.
Niederhauser C., Candrian U., Höfelein C., Jermini M., Bühler H.P., Lüthy J., 1992. Applied and Environmental Microbiology, 58 (5) pp. 1564-1568. Peer-reviewed.
 
Polymerase-Kettenreaktion in der bakteriologischen Lebensmitteldiagnostik am Beispiel von Listeria monocytogenes.
Candrian U., Niederhauser C., Höfelein C., Bühler H.P., Müller U., Lüthy J., 1991. Gebiete der Lebensmittelhygiene, 82 pp. 539-588. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University